Fundz

Ce Ro Therapeutics Holdings reported raising $1.25 Million in an initial SEC Form D filing, from an offering of $1.25 Million

PUBLIC · CEROOct 04, 2024

Amount Raised

$1.25 Million

$1.25 Million sold, per SEC Form D (first sale Sep 26, 2024)

Round Type

Seed

South San FranciscoOtherBiotechnologyHealth CareTherapeutics

Quick answer

CERo Therapeutics Holdings raised $1.25 Million in a Seed round, dated September 26, 2024. CERo Therapeutics Holdings is based in South San Francisco, California, United States.

How much did CERo Therapeutics Holdings raise?
CERo Therapeutics Holdings raised $1.25 Million in a Seed round on September 26, 2024.
What does CERo Therapeutics Holdings do?
CERo Therapeutics Holdings, Inc. is an innovative immunotherapy company focused on advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer.
Where is CERo Therapeutics Holdings based and how big is it?
CERo Therapeutics Holdings is based in South San Francisco, California, United States. Fundz records about 16 employees.
Who are the decision-makers at CERo Therapeutics Holdings?
Fundz holds 1 contact at CERo Therapeutics Holdings. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as CERo Therapeutics Holdings that raised within 45 days of this round, from Fundz verified event records.

  • Strata Oncology raised $6.1M on November 8, 2024.
  • TRex Bio raised $42M on November 7, 2024.
  • Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
  • CrossBridge Bio raised $10M (Seed) on November 4, 2024.
  • Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.
  • Archon Biosciences raised $20M (Seed) on October 30, 2024.

Who to call at CERo Therapeutics Holdings, and when

A new round usually means CERo Therapeutics Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CERo Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CERo Therapeutics Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CERo Therapeutics Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CERo Therapeutics Holdings

Location

201 Haskins Way

South San Francisco, California, United States

About

CERo Therapeutics Holdings, Inc. is an innovative immunotherapy company focused on advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy, redirecting patient-derived T cells to eliminate tumors by employing phagocytic mechanisms. CERo anticipates initiating clinical trials for its lead product candidate, CER-1236, in 2024 for hematological malignancies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CERo Therapeutics Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts3 people are listed at CERo Therapeutics Holdings. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CERo Therapeutics Holdings's next move

See what Strategic adds

CERo Therapeutics Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.